Diminished HLA-DR expression on monocyte and dendritic cell subsets indicating impairment of cellular immunity in pre-term neonates: a prospective observational analysis by Schefold, Joerg C. et al.
J. Perinat. Med. 2014; aop
 Joerg C.  Schefold * ,  Linn  Porz ,  Barbara  Uebe ,  Holger  Poehlmann a ,  Stephan  von Haehling , 
 Andreas  Jung ,  Nadine  Unterwalder and  Christian  Meisel 
 Diminished HLA-DR expression on monocyte 
and dendritic cell subsets indicating impairment 
of cellular immunity in pre-term neonates: a 
prospective observational analysis 
 Abstract 
 Aims: The risk of neonates for severe infection/sepsis is 
reciprocally proportional to gestational age and birth 
weight. As monocytes and dendritic cells (DC) are recog-
nised key antigen-presenting immune cells, we aimed to 
elucidate whether neonatal age is associated with reduced 
expression of human-leukocyte antigen-DR (HLA-DR) 
antigens on subsets of monocytes and DCs. 
 Methods: Forty-three consecutive neonates (20 male, 
mean gestational age 236.0 ± 26.8 days; mean 1-min Apgar 
score 7.5 ± 2.0) were included in a monocentric prospective 
observational analysis. Patients were grouped according 
to gestational age (n = 15 full-term, n = 28 pre-term defined 
as  < 33 weeks). Ten healthy adult volunteers were assessed 
also. Flow-cytometric assessment of HLA-DR expression 
was performed in subsets of peripheral blood myeloid and 
plasmacytoid DCs (MDC and PDC) and monocytes (CD14 bright-
 CD16 negative /CD14 positive CD16 positive /CD14 dim CD16 positive ). 
Clinical and routine laboratory data were followed up. 
 Results: At birth, leukocyte counts were increased in 
full-term neonates. Monocyte counts were significantly 
increased in neonates when compared with adults (all 
P < 0.05). A significant numerical increase of CD14 bright-
 CD16 negative and CD14 positive CD16 positive monocytes was noted 
in pre-term and full-term neonates (all P < 0.05), while 
HLA-DR expression in these subsets was significantly 
diminished (most pronounced in pre-term infants, 
P < 0.0001). MDC and PDC HLA-DR expression was 
reduced also (all P < 0.05). Clinical indices (e.g., pH, days 
on antibiotics/mechanical ventilation, fever/sepsis) were 
not found to correlate with immunological indices. 
 Conclusions: We observed a markedly diminished HLA-
DR expression on monocyte and DC subsets in pre-term 
and full-term neonates, which may contribute to impaired 
antimicrobial defence mechanisms in the early days of 
life. 
 Keywords:  Dendritic cells;  HLA-DR;  immunoparalysis; 
 inflammation;  monocytes;  organ failure;  sepsis;  septic 
shock;  severe infection. 
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 Introduction 
 Severe infection or sepsis is more often observed in neo-
nates with low gestational age or low weight at birth. This 
seems especially evident in very pre-term ( < 28.0 weeks 
of gestational age) or very low weight (i.e.,  < 1500 g) neo-
nates. Here, risks of infection and mortality rates are 
especially high  [1 – 5] . It is currently acknowledged that 
not only organ-specific complications (e.g., intracranial 
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bleedings, bronchopulmonary dysplasia) contribute to 
increased rates of infection, but cellular immune function 
may also be immature. Interestingly, immune response to 
vaccination in the first year of life is markedly diminished 
in pre-term when compared with full-term neonates of 
same postnatal age. This may indicate a profound and 
persisting immunodeficiency in pre-term neonates in 
early life  [1, 4 – 6] . However, data on functional immunity 
in this population are scarce, and underlying immuno-
logical mechanisms are incompletely understood. 
 The host response to invasive microbial infection 
includes several crucial  “ defence lines ” of innate and 
acquired immunity. In adults, numerous immune dys-
functions were reported in sepsis including altered 
cytokine expression profiles, immune cell apoptosis, and 
diminished expression of major histocompatibility (MHC) 
class II molecules on antigen-presenting cells (APC)  [7 – 9] . 
Previously, we and others could demonstrate that dimin-
ished monocytic expression of the MHC class II molecule 
human-leukocyte antigen-DR (HLA-DR) reflects dimin-
ished immune cellular functionality and often occurs in 
late sepsis  [7] . Low monocytic HLA-DR (mHLA-DR) expres-
sion was found to indicate patients at risk to develop 
infectious complications after major trauma, burn, or 
surgery  [10] . In sepsis, persistent diminished mHLA-DR 
was also termed sepsis-associated immunosuppression 
(SAI) and is associated with adverse outcome. Clinical 
pilot trials aiming at SAI reversal showed that this can be 
achieved by both immunostimulation and reduction of 
systemic inhibitors  [11, 12] . Nevertheless, whether or not 
SAI reversal improves clinical outcomes from sepsis is cur-
rently investigated. 
 In neonates, monocytes appear at weeks 18 – 20 in the 
circulation, and a constant physiological increase in total 
numbers occurs until birth  [1 – 5, 10] . Consequently, pre-
term neonates mostly have diminished monocyte counts 
 [1, 4, 5, 13, 14] . However, in contrast to the extensively 
studied major population of classical CD14 bright monocytes, 
little knowledge exists on Fc γ receptor III positive (i.e., 
CD16 bright ) monocytes in neonates. This subpopulation 
was referred to as  “ pro-inflammatory monocytes ” ( ∼ 10% 
of circulating monocytes in adults) and expresses higher 
pro-inflammatory stimulation-induced cytokine levels. 
HLA-DR expression of CD14 bright CD16 negative monocytes has 
been shown reduced in pre-term neonates. 
 Dendritic cells (DCs) are considered the most potent 
APCs and link innate and adaptive immune responses  [15] . 
Mature DCs typically express high numbers of HLA-DR 
molecules. Two major DC phenotype subsets can be dis-
tinguished in peripheral blood: myeloid (MDC) and plas-
macytoid DCs (PDC). These DC subsets are functionally 
different in regard to mode of activation, cytokine release, 
and effector function. Activation of MDCs by microbial 
products (e.g., lipopolysaccharides) results in the secre-
tion of pro-inflammatory cytokines (e.g., tumor necro-
sis factor- α ), whereas PDCs produce large amounts of 
interferon- α and enhance antiviral defence. Interestingly, 
animal sepsis models and human data indicate that com-
promised DC function is associated with adverse out-
comes  [16] . 
 In an effort to better understand the immune patho-
physiology, we investigate phenotypic differences in 
monocyte and DC subsets in pre-term and full-term 
neonates. 
 Materials and methods 
 Population and protocol 
 In a tertiary-care academic centre, a total of 43 consecutive neonates 
were included in a monocentric prospective observational analy-
sis. Between December 2005 and July 2007, n = 28 pre-term (defi ned 
as  < 33 weeks of gestational age;  “ pre-term group ” ) neonates and 
n = 15 full-term neonates (defi ned as  > 36 weeks;  “ full-term group ” ) 
were included. Ten healthy adult volunteers were assessed also 
(comparison group, aged 27.7 ± 3.92 years, means ± SD). The observa-
tional analysis was performed at the Department of Neonatology, 
Charit é University Hospital, Campus Mitte, Berlin, Germany. Inclu-
sion criteria were the following: gestational age according to groups 
 “ pre-term ” and  “ full-term ” (see above). Exclusion criteria were the 
following: denial of consent by parents, pre-existing chromosomal 
anomalies, innate congenital atypical infections such as cytomegalo-
virus/rubella/parvovirus B19 infection, HIV positivity, and indica-
tion of toxoplasmosis or tuberculosis (TBC). Informed consent was 
achieved from parents/legal representatives. The study was per-
formed in adherence to the Declaration of Helsinki and approved by 
the local ethics committee on human research. 
 Points in time of clinical and laboratory assessment 
 Patients were assessed at the following points in time: T1: 72 – 96 h 
post partum, T2: 96 – 120 h post partum, T3: day 11 ( ± 3 days), T4: day 
18 ( ± 3 days), T5: day 25 ( ± 3 days). Full-term neonates and adult con-
trols were assessed at a single time point only (T1 for full-term neo-
nates). Comparison of data from the full term/pre-term group with 
the data derived from samples of healthy adults was performed at 
this point in time only. Clinical data including age, ethnicity, ges-
tational/morphological age, twin/multiple birth, mode of delivery 
(e.g., caesarean section), weight, Apgar score, Clinical Risk Index 
for Babies (CRIB) score, FiO 2 , vital signs, temperature, and antibi-
otic medication were recorded. If available, the following laboratory 
indices were assessed: pH at birth, haematocrit, haemoglobin con-
centration, total bilirubin levels, C-reactive protein, platelet counts, 
and total white blood cell (WBC)/monocyte count. Quantifi cation of 
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immune phenotypic markers was performed in the certifi ed immuno-
logical laboratory (Institute of Medical Immunology, Charit é Univer-
sity Hospital, Berlin, Germany). 
 Quantifi cation of HLA-DR expression and analysis of DC 
subsets 
 Quantifi cation of HLA-DR on circulating monocytes was performed 
using a standardised fl ow cytometric assay (QuantiBRITE HLA-DR, 
BD Biosciences, Heidelberg, Germany), as described elsewhere  [17] . 
Enumeration of DC subsets was performed as described elsewhere 
 [16] . In short, 150  μ L of whole blood was stained with fl ourescein 
isothiocyanate-conjugated antibodies against lineage (lin1) markers 
(mixture of anti-CD3/CD14/CD16/CD19/CD20/CD56), anti-CD123-PE, 
anti-HLA-DR-PerCP, and anti-CD33-APC (BD Biosciences, Heidelberg, 
Germany). PDC were gated as lin1- CD123 + HLA-DR + events and MDC 
as lin1- CD33 + HLA-DR + . Aft er treatment with FACS Lysing Solution, 
at least 300 events per DC population were analyzed on a FACSCali-
bur using CellQuest Pro (BD Biosciences, Heidelberg, Germany) soft -
ware. HLA-DR expression on DCs was measured as mean fl uorescence 
intensity. Absolute APC population frequencies were calculated as 
WBC counts multiplied by the ratio of the APC population over all 
 leukocytes. The gating strategy is given ( Figure 1 ). 
 Statistical analysis 
 For statistical analyses, MedCalc 12.0 (MedCalc, Mariakerke, Belgium) 
was used. Data are given as mean ± SD, if not indicated otherwise. Data 
were checked for normal distribution using the Kolmogorov-Smirnov 
test; for summary data, please refer to respective analysis. Patients 
who fulfi lled the entry criteria including provision of informed con-
sent entered the analysis. An initial formal power analysis/sample 
size calculation was not performed. Observation of eff ects was con-
sidered the focal point. P < 0.05 was considered signifi cant. 
 Results 
 Study population and follow-up 
 Study population details are given in  Table 1 . A total of 
n = 43 patients (20 male, mean gestational age 236.0 ± 26.8 
days; mean 1-min Apgar score 7.5 ± 2.0) were included. 
Distribution of gender, ethnicity, and baseline pH did 
not differ between the pre-term and full-term groups. As 
expected, significant between-group differences were 
noted in gestational age, morphological age, and weight 
at birth (all P < 0.0001). The mode of delivery differed 
between groups, with a higher prevalence of caesarian 
section and twin/multiple births in the pre-term group 
(Table 1). Apgar scores differed significantly also. At 1, 5, 
and 10 min, significantly lower Apgar scores were noted in 
pre-term individuals. In the pre-term group, n = 2 patients 
developed severe sepsis/septic shock, and a total of n = 7 
developed infant/acute respiratory distress syndrome 
(IRDS/ARDS). Patients in the pre-term group received 
mechanical ventilation for 8.0 ± 9.4  days (mean ± SD), 
and antibiotic treatment was performed for 2.8 ± 4.7 days 
(Table  1). All patients survived. Overall, we regard the 
two groups to reflect typical neonate cohorts treated at 
a tertiary-care academic centre. The comparison group 
(n = 10) consisted of healthy laboratory personnel (aged 
27.7 ± 3.9 years at the time the trial was ended). 
 Distribution of leukocytes and monocytes 
subsets in neonates 
 According to respective CD14 and CD16 surface expres-
sions, three distinct monocyte subsets can be identi-
fied in the peripheral blood:  “ classical ” monocytes 
(i.e., CD14 bright CD16 negative ),  “ pro-inflammatory ” mono-
cytes (CD14 negative CD16 positive ), and  “ transition ” monocytes 
(CD14 positive CD16 positive ). At baseline, it was found that both 
total circulating WBC counts and the total number of 
circulating monocytes were increased in both neonate 
groups (all P < 0.05 except WBC in pre-term individuals) 
when compared with adults ( Figure 2 A and B, respec-
tively). Numbers of CD14 bright CD16 negative monocytes were 
increased in both pre-term and full-term neonates when 
compared with controls. Statistically significant differ-
ences were not noted between the pre-term and full-term 
neonate groups (Figure 2C). Circulating levels of CD14 posi-
tive CD16 positive monocytes were found significantly increased 
in both pre-term and full-term neonates when compared 
with adults (Figure 2D). The total number of CD14 dim CD-
16 positive monocytes was elevated in full-term but not pre-
term neonates when compared with adults (Figure 2E). 
 Distribution of dendritic cells (subsets) in 
neonates 
 Human peripheral blood contains at least two distinct pop-
ulations of DCs. In the current prospective investigational 
analysis, the number and function of PDC (i.e., lineage 
CD123 + HLA-DR + DCs) and MDC (i.e., lineage- CD33 + HLA-
DR + DCs) were investigated. Compared with adult healthy 
controls, the MDC numbers were reduced in neonates 
(5.3 ± 3.0 and 6.1 ± 4.5/ μ L for pre-term/full-term neonates, 
respectively) when compared with adults (13.0 ± 4.4/ μ L). 
The number of PDCs were comparable in the groups 
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 Figure 1   Gating strategy and HLA-DR expression on dendritic cell (DC) and monocyte subsets. Mononuclear cells were gated using a 
forward scatter/side scatter (SSC) dot plot, and HLA-DR positive cells were identified using a HLA-DR/SCC dot plot ( A ). Plasmacytoid DC 
(PDC) were defined as HLA-DR + BDCA-2 + cells using a BDCA-2/SSC dot plot ( B ), and myeloid DC (MDC) were identified as CD14- CD33 + + 
cells using a CD14/CD33 dot plot ( C ). According to their differential expression of CD14/CD16, three monocyte subsets were defined: 
CD14 + + CD16 + , CD14 + CD16 + , and CD14 + /-CD16 + + ( D ). Examples of HLA-DR expression on DC and monocyte subsets are given in the histo-
gram plots ( E ) and ( F ). 
Bereitgestellt von | Universitätsbibliothek Bern
Angemeldet
Heruntergeladen am | 12.02.15 16:06
J.C. Schefold et al., Monocyte/DC subsets in neonates      5
 Table 1   Baseline demographics, disease severity, and clinical follow-up. 
 Pre-term 
group (n = 28) 
Full-term 
group (n = 15) 
Between-
group P-value 
Gestational age (days) 218.4 ± 11.5 268.9 ± 10.7  < 0.0001
Gender (male) 11 (39%) 9 (60%)  = 0.22 a 
Morphological age
   (weeks) 31.6 ± 1.6 38.1 ± 1.4  < 0.0001
   (days) 221.2 ± 10.9 266.9 ± 9.9  < 0.0001
Body weight (g) 1448 ± 336 3346 ± 430  < 0.0001
Baseline blood pH (at delivery, venous blood sample) 7.3 ± 0.1 7.3 ± 0.1 0.30
Ethnicity (Caucasian patients) 23 (82%) 15 (100%) 0.14 a 
Delivery mode (caesarean section) 21 (75%) 5 (33%) 0.01 a 
Twin birth/multiple birth 13 (46%) 1 (6%) 0.01 a 
Development of severe sepsis/septic shock (follow-up period) 2 (7%) 0 (0%) 0.54 a 
Development of respiratory distress syndrome (follow-up period) 7 (25%) 0 (0%) 0.08 a 
Apgar score
   At 1 min post partum 6.9 ± 2.1 8.6 ± 1.5 0.01
   At 5 min post partum 7.9 ± 1.4 9.2 ± 0.8 0.001
   At 10 min post partum 8.7 ± 0.7 9.5 ± 0.7 0.002
CRIB score
   Total CRIB score at birth 1.0 ± 1.1  –  – 
   CRIB value: birth weight 0.6 ± 0.8  –  – 
   CRIB value: gestational age (weeks) 0.0 ± 0.0  –  – 
   CRIB value: congenital dysplasia 0.1 ± 0.3  –  – 
   CRIB value: maximum base deficit (12 h) 0.2 ± 0.7  –  – 
Clinical follow-up
   Days on mechanical ventilator 8.0 ± 9.4  –  – 
   Days on vasopressors 0.04 ± 0.2  –  – 
   Days on antibiotics 2.8 ± 4.7  –  – 
   Days with central venous line 1.9 ± 4.5  –  – 
   Days with apnoea episodes(in 28 days) 3.1 ± 4.4  –  – 
   Days with fever ( > 38 ° , within 28 days) 0.7 ± 1.2  –  – 
   Urinary catheterisation (days) 0.4 ± 2.1  –  – 
   GI tube feeding (days) 25.8 ± 3.6  –  – 
   Transfusion: erythrocyte concentration (mL) 117.8 ± 325.0  –  – 
 a Fisher’s exact test was used for analysis of significance levels. 
investigated (4.7 ± 3.4, 7.7 ± 4.1, and 6.4 ± 5.4/ μ L in pre-term 
neonates, full-term neonates, and adult controls). 
 HLA-DR expression on monocyte and DC 
subsets 
 Reduced HLA-DR expression on APC such as monocytes 
and DCs is a key feature of immunodepression in major 
trauma, burn, or sepsis. Although data exist on HLA-DR 
expression on CD14 bright CD16 negative monocytes in neonates, 
only few data are available on the expression of HLA-DR in 
monocyte and DC subsets in pre-term and full-term neo-
nates. This seems important as  “ immune function ” is not 
only a consequence of normal levels of circulating respec-
tive immune cells but also a consequence of immune func-
tionality. HLA-DR expression on CD14 bright CD16 negative and 
CD14 positive CD16 positive monocytes (in Ab/cell) was strongly 
reduced in neonates, and this effect was most pronounced 
in pre-term individuals ( Figure 3 A and B). Interestingly, 
this effect was not observed in CD14 negative CD16 positive mono-
cytes (Figure 3C). In this subgroup, HLA-DR expression 
was enhanced in full-term infants, while HLA-DR expres-
sion in pre-term infants was comparable with that of adult 
controls (Figure 3C). When compared with adults, base-
line HLA-DR expression on both MDC (Figure 3D) and PDC 
(Figure 3E) was reduced in both pre-term and full-term 
neonates. 
 Course of immune function (monocytes and 
DC subsets) in neonates 
 To assess the course of immune function in pre-term new-
borns, we assessed the expression of HLA-DR in mono-
cytes and DC cells over time ( Table 2 ). HLA-DR significantly 
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 Figure 2   The absolute number of circulating immune cells in pre-term (group 1) and full-term (group 2) neonates at baseline is given 
(cells/ μ L) and compared with the number of circulating cells in adult healthy controls (control group: group 3). ( A ) Total number of 
circulating white blood cells (WBC), ( B ) total number of circulating monocytes, ( C ) total number of circulating CD14 bright CD16 negative 
( “ classical ” ) monocytes, ( D ) total number of circulating CD14 positive CD16 positive ( “ transition ” ) monocytes, and ( E ) total number of circulating 
CD14 dim CD16 positive ( “ pro-inflammatory ” ) monocytes. *P < 0.05, **P < 0.01, ***P < 0.001; independent samples  t -test. 
increased on all three monocyte subsets from T1 to T5 and 
thus tended towards normalisation/the levels observed 
in adult healthy controls (Table 2). With regard to DCs, it 
was noted that the HLA-DR expression on MDCs increased 
over time, reaching levels comparable with levels of adult 
controls on T4/T5. Interestingly, the level of HLA-DR on 
PDCs remained unchanged over the observational inter-
val (Table 2). 
 Correlation of HLA-DR expression with 
clinical indices 
 A significant correlation of gestational age with the degree 
of mHLA-DR expression on all three subsets was noted: 
increased gestational age was strongly associated with 
increased mHLA-DR expression (P < 0.001 for all compari-
sons). In DCs, this relation was not noted (P = 0.85 and P = 0.1 
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 Figure 3   Baseline HLA-DR expression on respective monocyte and DC subsets (given in mAb/cell) in pre-term (group 1) and full-term (group 
2) neonates compared with adult healthy controls (group 3). ( A ) circulating CD14 bright CD16 negative ( “ classical ” ) monocytes, ( B ) CD14 positive CD-
16 positive ( “ transition ” ) monocytes, and ( C ) CD14 dim CD16 positive ( “ pro-inflammatory ” ) monocytes. ( D ) Circulating MDCs. ( E ) circulating PDCs. 
*P < 0.01, **P < 0.001, ***P < 0.0001; independent samples  t -test. 
for MDCs and PDCs, respectively). Interestingly, reduced 
weight at birth was significantly associated with dimin-
ished HLA-DR expression in CD14 bright CD16 negative , CD14 positive 
CD16 positive , and CD14 negative CD16 bright monocytes (P < 0.001 
for all comparisons), whereas this was not noted in MDCs 
and PDCs (P = 0.44 and P = 0.35, respectively). Moreover, 
no association was observed between pH at birth and 
the expression of HLA-DR on monocytes or DCs in both 
pre-term and full-term neonates. Interestingly, we found 
a strong association of 1-min Apgar scores with mHLA-DR 
expression (all P < 0.02). Furthermore, we investigated 
whether total days on antibiotics was associated with 
HLA-DR expression of monocytes or DCs. Antibiotics were 
given in 16 patients, and mean total days on antibiotics 
was 2.8 ± 4.7 days. No significant association between total 
days on antibiotics or total days on mechanical ventilation 
(28-day observational period) with monocytic/DC HLA-DR 
expression was found (all P > 0.2). The number of apnoea 
episodes and days with hyperthermia ( > 38.0 ° C) were not 
associated with monocytic or DC HLA-DR expression. 
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   Group of patients with respiratory distress 
 In seven infants (all pre-term), respiratory distress syn-
drome was noted. In this group, gestational age was 
significantly reduced (210.6 ± 17.1  days (IRDS group) vs. 
241.2 ± 25.9 days (group without IRDS), P = 0.0005). Weight 
at birth was significantly reduced in this group also 
(1442.9 ± 407.4 g (IRDS group) vs. 2257.1 ± 1024.7 g (group 
without IRDS), P = 0.05). HLA-DR on CD14 bright CD16 negative 
and CD14 positive CD16 positive monocytes was significantly 
down-regulated in patients with IRDS (5285 ± 3128 vs. 
16,239 ± 12,403 mAb/cell for CD14 bright CD16 negative monocytes 
(P = 0.03) and 11,986 ± 3255 vs. 54,865 ± 51,386 mAb/cell for 
CD14 positive CD16 positive monocytes (P = 0.04), respectively). 
Given the limited number of IRDS cases, respective data 
must be interpreted with caution. A multifactorial analy-
sis was therefore not performed. 
 Discussion 
 Severe infection is a serious and life-threatening condi-
tion especially in pre-term neonates. The risk of pre-term 
neonates to acquire severe infection or sepsis is recipro-
cally proportional to gestational age and birth weight. As 
monocytes and DCs are recognised key antigen-presenting 
immune cells, we aimed to elucidate whether diminished 
gestational age is associated with reduced expression of 
HLA-DR antigens on monocyte and DC subsets. This was 
performed in order to better understand the complex 
immune pathophysiology in the neonatal age. 
 We observed that at birth, total leukocyte and mono-
cyte counts were found increased when compared with 
adults, a previously described fact that could at least par-
tially be attributable to stress. When subgroups of mono-
cytes were investigated (CD14 bright CD16 negative , CD14 positive 
CD16 positive , and CD14 dim CD16 positive ), we observed that the 
total number of CD14 bright CD16 negative and CD14 positive CD16 positive 
monocytes was increased in pre-term and full-term 
newborns. Interestingly, this effect was not observed in 
pre-term infants in the monocyte subset referred to as 
 “ pro-inflammatory ” (CD14 dim CD16 positive ), whereas respec-
tive levels were increased in full-term infants. Although 
we are unable to elucidate the mechanisms behind this, 
it seems tempting to speculate that reduced total numbers 
of CD14 dim CD16 positive monocytes might indicate an addi-
tional lack of immunocompetence. Moreover, we inves-
tigated the number of MDCs and PDCs in the respective 
study groups. At baseline, PDCs were rather unchanged 
between the three study groups, whereas MDCs were 
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found reduced in pre-term and full-term infants compared 
with adults. 
 As protective immune reponses depend on effective 
antigen presentation and induction of adaptive immune 
mechanisms, we investigated cellular immune function 
also. To assess cellular immune function, the quantitative 
surface HLA-DR expression was assessed on monocyte 
and DC subsets. A major reduction in HLA-DR expres-
sion in CD14 bright CD16 negative and CD14 positive CD16 positive mono-
cytes in newborns was noted. Before the background of 
increased total cell numbers, this indicates functional 
deactivation rather than numerical down-regulation. 
In addition to respective cell counts of CD14 dim CD16 positive 
monocytes, HLA-DR expression on this specific subpopu-
lation of monocytes was unchanged. This may indicate 
that functional deactivation of monocytes mainly occurs 
in  “ classical ” rather than  “ pro-inflammatory ” mono-
cytes. In addition, DC subsets (i.e., MDC and PDC) showed 
diminished HLA-DR surface expression. However, when 
compared with monocyte subsets, this effect was less 
pronounced. 
 From a clinical perspective, we were interested 
whether the observed immunological changes were asso-
ciated with clinical parameters of immaturity. We found 
that lower gestational age and birth weight was signifi-
cantly associated with diminished mHLA-DR expression 
(P < 0.001 for all subsets), whereas this was not observed 
in MDCs and PDCs. However, venous pH at birth, days 
on antibiotics or mechanical ventilation, total number of 
apnoea episodes, development of hyperthermia/sepsis, 
and Apgar scores were not found to correlate with respec-
tive immunological indices. 
 There are a number of limitations of our analysis that 
seem important to discuss. First, the number of study 
patients investigated was rather limited and the overall 
recruitment period was rather long. This implies an 
obvious major limitation of our analysis and, by defini-
tion, we cannot rule out an effect of low sample size on 
our findings. Moreover, a formal sample size calculation 
or power analysis was not performed. This was due to the 
observational proof-of-concept character of the analy-
sis. Importantly, we are therefore unable to investigate, 
e.g., gender-related differences, differences induced by 
the mode of delivery, or other clinical endpoints/effects. 
Second, provision of informed consent by respective legal 
proxies was necessary and patients were deliberately 
recruited on a consecutive basis. By definition, this might 
have introduced a bias to the analysis also. Third, due to 
restrictions in blood volume, we were able to investigate 
a limited set of immune parameters only. Fourth, we were 
unable to systematically access a potential influence of 
the respective mothers ’ immune status on the immune 
system of respective newborns. This was beyond the 
scope of the analysis and should be investigated in sub-
sequent analyses. Fifth, we are unable to conclude on the 
underlying pathomechanism of decreased MHC class II 
expression on APC as this was beyond the scope of our 
analysis. 
 Conclusion 
 In conclusion, we demonstrate a profound and sustained 
functional impairment of circulating CD14 bright CD16 negative 
and CD14 positive CD16 positive monocytes in pre-term and full-
term newborns. This state of functional immunological 
immaturity may contribute to impaired antimicrobial 
defence mechanisms. Further studies are required to elu-
cidate the individual role of distinct APC populations in 
neonatal infection/sepsis and whether functional APC 
reconstitution may prevent infectious complications and 
improve outcomes. 
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